Dashboard
Manage Tickers

IOVA IOVANCE BIOTHERAPEUTICS, INC.

Nasdaq iovance.com


$ 2.32 $ 0.05 (2.22 %)    

Friday, 07-Nov-2025 19:58:09 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 2.3
$ 2.25
$ 2.21 x 26
$ 2.35 x 1
$ 2.08 - $ 2.38
$ 1.64 - $ 10.86
29,618,692
na
913.03M
$ 1.29
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2025 09-30-2025 10-Q
2 08-07-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-27-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 02-28-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 02-28-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-24-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 11-04-2019 09-30-2019 10-Q
26 08-01-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 02-28-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-12-2018 12-31-2017 10-K
33 11-02-2017 09-30-2017 10-Q
34 08-03-2017 06-30-2017 10-Q
35 05-03-2017 03-31-2017 10-Q
36 03-09-2017 12-31-2016 10-K
37 11-04-2016 09-30-2016 10-Q
38 08-09-2016 06-30-2016 10-Q
39 05-09-2016 03-31-2016 10-Q
40 03-11-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

chardan-capital-maintains-buy-on-iovance-biotherapeutics-lowers-price-target-to-17
Chardan Capital Maintains Buy on Iovance B...
11/06/2025 23:06:22

Chardan Capital analyst Geulah Livshits maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and lowers the price targ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
11/06/2025 17:05:48

iovance-biotherapeutics-affirms-fy2025-sales-guidance-of-250000m-300000m-vs-264918m-est
Iovance Biotherapeutics Affirms FY2025 Sal...
11/06/2025 13:01:20

Iovance Biotherapeutics (NASDAQ:IOVA) affirms FY2025 sales outlook from $250.000 million-$300.000 million to $250.000 million-$...

iovance-biotherapeutics-q3-eps-025-beats-026-estimate-sales-67455m-miss-72402m-estimate
Iovance Biotherapeutics Q3 EPS $(0.25) Bea...
11/06/2025 13:00:57

Iovance Biotherapeutics (NASDAQ:IOVA) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate ...

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

examining-the-future-iovance-biotherapeuticss-earnings-outlook
Examining the Future: Iovance Biotherapeut...
11/05/2025 18:02:31

iovance-biotherapeutics-interim-data-from-phase-2-iov-lun-202-trial-of-lifileucel-monotherapy-for-previously-treated-patients-with-advanced-nonsquamous-nsclc-without-actionable-genetic-mutations-showed-26-objective-response-rate
Iovance Biotherapeutics' Interim Data From...
11/03/2025 12:03:33

The objective response rate (ORR) was 25.6% by RECIST v1.1 following one-time treatment with lifileucel monotherapy in patients...

hc-wainwright--co-maintains-buy-on-iovance-biotherapeutics-lowers-price-target-to-9
HC Wainwright & Co. Maintains Buy on Iovan...
10/29/2025 17:38:18

HC Wainwright & Co. analyst Joseph Pantginis maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and lowers the p...

keurig-dr-pepper-valneva-venu-holding-and-other-big-stocks-moving-lower-on-monday
Keurig Dr Pepper, Valneva, Venu Holding An...
08/25/2025 16:02:33

iovance-biotherapeutics--enters-amended-sale-agreement-with-jefferies-may-sell-up-to-350m-of-common-stock
Iovance Biotherapeutics Enters Amended Sa...
08/22/2025 21:23:44

-SEC Filing

intel-plymouth-industrial-reit-premier-and-other-big-stocks-moving-higher-on-tuesday
Intel, Plymouth Industrial REIT, Premier A...
08/19/2025 15:00:01

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 12:08:33

why-palo-alto-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket
Why Palo Alto Shares Are Trading Higher By...
08/19/2025 12:01:09

hc-wainwright--co-reiterates-buy-on-iovance-biotherapeutics-maintains-20-price-target
HC Wainwright & Co. Reiterates Buy on Iova...
08/19/2025 11:06:56

HC Wainwright & Co. analyst Joseph Pantginis reiterates Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and maintains $...

iovance-biotherapeutics-receives-health-canada-nocc-for-amtagvi
Iovance Biotherapeutics Receives Health Ca...
08/18/2025 20:24:10

First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD...

what-7-analyst-ratings-have-to-say-about-iovance-biotherapeutics
What 7 Analyst Ratings Have To Say About I...
08/08/2025 18:01:05

wells-fargo-maintains-overweight-on-iovance-biotherapeutics-lowers-price-target-to-14
Wells Fargo Maintains Overweight on Iovanc...
08/08/2025 15:30:29

Wells Fargo analyst Yanan Zhu maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight and lowers the price target ...

pinterest-posts-downbeat-q2-earnings-joins-twilio-trade-desk-and-other-big-stocks-moving-lower-in-friday-pre-market-session
Pinterest Posts Downbeat Q2 Earnings, Join...
08/08/2025 12:43:36

chardan-capital-maintains-buy-on-iovance-biotherapeutics-lowers-price-target-to-20
Chardan Capital Maintains Buy on Iovance B...
08/08/2025 12:15:00

Chardan Capital analyst Geulah Livshits maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and lowers the price targ...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/08/2025 12:08:44

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION